Dextrose Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
About Dextrose Technologies
Dextrose Technologies Private Limited (DTPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 November 2017 (Seven years and three months 16 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Arjun Sridharan and Ganessin Aravind serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100KA2017PTC107735
- Company No.
107735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Nov 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Dextrose Technologies Private Limited offer?
Dextrose Technologies Private Limited offers a wide range of products and services, including Testing & Measuring Equipments, TDS Meter, Material Testing Labs & Services, Laboratory Testing Services, Warehouses and Warehousing Agents, Freezers, Surgical & ICU Equipments, Patient Monitoring System, Test Kits, Dryers & Evaporators.
Who are the key members and board of directors at Dextrose Technologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arjun Sridharan  | Director | 06-Jan-2023 | Current |
| Ganessin Aravind | Director | 08-Nov-2017 | Current |
Financial Performance of Dextrose Technologies.
Enhance accessibility to Dextrose Technologies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dextrose Technologies?
Unlock access to Dextrose Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Intergene Biosciences Private LimitedGanessin Aravind is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dextrose Technologies?
Unlock and access historical data on people associated with Dextrose Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dextrose Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dextrose Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
